Compare Nuwellis Inc (NUWE) vs First Trust NASDAQ 100 Technology Index Fund (QTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? Nuwellis Inc trades at $2.84 (market cap $1.09M), while First Trust NASDAQ 100 Technology Index Fund trades at $310.02. The key difference: First Trust NASDAQ 100 Technology Index Fund is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | QTEC | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $527.46 | $335.74 |
52-Week Low | $2.80 | $207.03 |
Enterprise Value | -$722.58K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.
Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.
QTEC trades at $301.50, up 0.53% today, with a bearish technical signal overall. Key support lies at $298 and resistance at $302. The ETF provides equal-weighted exposure to top technology firms, tracking the Nasdaq-100 Technology Sector Index. Recent news highlights its broad tech sector focus and questions on AI and chip stock valuations.
Outlook remains tied to technology sector performance, with risks from market volatility and sector-specific headwinds. Investment opportunity lies in targeted tech exposure, but caution is warranted given overheated valuations in segments like AI.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →
